Harpoon Therapeutics

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024
HARP$22.940%8071,028$862$11.00108.5%

Contact Information

611 Gateway Blvd., Suite 400,
South San Francisco, CA 94080

Harpoon is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that unleash the natural power of the T cells to fight cancer and other diseases.

At the heart of Harpoon’s approach is a novel antibody-derived platform called TriTAC® (Tri-specific T cell Activating Construct) designed for targeted penetration and destruction of solid tumors and hematologic malignancies, and engineered to bind to human serum albumin for improved therapeutic schedule and patient convenience.